Search

everythinglearnresearchcommunity

for

Search:↓

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Most cutaneous adnexal tumors examined were benign and resembled common skin tumors.

People with certain skin diseases often have more trouble understanding and describing their emotions, which can affect their health and treatment results.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

PRP shows promise for treating female hair loss but needs more research.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

PRP might help with hair growth, but the evidence is weak.

Androgenetic alopecia causes significant psychological distress, especially in women, and requires both medical and psychological support.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Spironolactone nano-formulations show promise for treating skin disorders, but more research is needed for safety and effectiveness.

Topical metformin shows promise for dental and skin treatments, including periodontitis, hair regrowth, wound healing, and acne.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

PRP shows promise but lacks consistent evidence and regulation.

PRP is an effective and safe treatment for female hair loss.

PRP injections can increase hair density in people with androgenic alopecia.

Platelet-rich plasma may improve hair density and count in male pattern hair loss, but more high-quality research is needed.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

Platelet-rich plasma (PRP) may improve healing in chronic wounds and vitiligo and promote hair regrowth, but more research is needed.

Oral spironolactone may be effective for female pattern hair loss with a low rate of side effects.